The Magnum Ice Cream Company N.V. Ordinary Shares vs Oruka Therapeutics Inc. Common Stock — how do they compare? The Magnum Ice Cream Company N.V. Ordinary Shares trades at $18.49 (market cap $10.72B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares is far larger — about 2.1× Oruka Therapeutics Inc. Common Stock's market cap, and The Magnum Ice Cream Company N.V. Ordinary Shares is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| MICC | ORKA | |
|---|---|---|
Market Cap | $10.72B | $5.18B |
Volume | 1,309,650 | 490,798 |
Sector | Consumer Staples | Health |
52-Week High | $20.42 | $113.08 |
52-Week Low | $13.06 | $26.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.14B | $4.31B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →